These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33487521)

  • 21. Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome.
    McMacken GM; Spendiff S; Whittaker RG; O'Connor E; Howarth RM; Boczonadi V; Horvath R; Slater CR; Lochmüller H
    Hum Mol Genet; 2019 Jul; 28(14):2339-2351. PubMed ID: 31220253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up of patients with congenital myasthenic syndrome caused by COLQ mutations.
    Wargon I; Richard P; Kuntzer T; Sternberg D; Nafissi S; Gaudon K; Lebail A; Bauche S; Hantaï D; Fournier E; Eymard B; Stojkovic T
    Neuromuscul Disord; 2012 Apr; 22(4):318-24. PubMed ID: 22088788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A COLQ Missense Mutation in Sphynx and Devon Rex Cats with Congenital Myasthenic Syndrome.
    Abitbol M; Hitte C; Bossé P; Blanchard-Gutton N; Thomas A; Martignat L; Blot S; Tiret L
    PLoS One; 2015; 10(9):e0137019. PubMed ID: 26327126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Congenital myasthenic syndrome with novel pathogenic variants in the COLQ gene associated with the presence of antibodies to acetylcholine receptors.
    Tay CG; Fong CY; Li L; Ganesan V; Teh CM; Gan CS; Thong MK
    J Clin Neurosci; 2020 Feb; 72():468-471. PubMed ID: 31831253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Congenital myasthenic syndrome by mutation of the ColQ gene: Phenotypic and evolutionary profile of three Algerian families.
    Kediha MI; Tazir M; Magnouche C; Sternberg D; Belarbi S; Eymard B; Ali Pacha L
    Rev Neurol (Paris); 2023 Jun; 179(6):570-575. PubMed ID: 36764859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Congenital myasthenic syndrome: Ten years clinical experience from a quaternary care south-Indian hospital.
    Wadwekar V; Nair SS; Tandon V; Kuruvilla A; Nair M
    J Clin Neurosci; 2020 Feb; 72():238-243. PubMed ID: 31889643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation in the human acetylcholinesterase-associated collagen gene, COLQ, is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency (Type Ic).
    Donger C; Krejci E; Serradell AP; Eymard B; Bon S; Nicole S; Chateau D; Gary F; Fardeau M; Massoulié J; Guicheney P
    Am J Hum Genet; 1998 Oct; 63(4):967-75. PubMed ID: 9758617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delayed diagnosis of congenital myasthenia due to associated mitochondrial enzyme defect.
    Guo Y; Menezes MJ; Menezes MP; Liang J; Li D; Riley LG; Clarke NF; Andrews PI; Tian L; Webster R; Wang F; Liu X; Shen Y; Thorburn DR; Keating BJ; Engel A; Hakonarson H; Christodoulou J; Xu X
    Neuromuscul Disord; 2015 Mar; 25(3):257-61. PubMed ID: 25557462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Congenital Myasthenic Syndrome: Spectrum of Mutations in an Indian Cohort.
    Selvam P; Arunachal G; Danda S; Chapla A; Sivadasan A; Alexander M; Thomas MM; Thomas NJ
    J Clin Neuromuscul Dis; 2018 Sep; 20(1):14-27. PubMed ID: 30124556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COLQ-Related Congenital Myasthenic Syndrome in a Child from Western India.
    Pallithanam JJ; Prabhudesai SP; Naik N; Gauns S
    Neurol India; 2021; 69(1):228-229. PubMed ID: 33642313
    [No Abstract]   [Full Text] [Related]  

  • 31. Congenital myasthenic syndrome in Israel: Genetic and clinical characterization.
    Aharoni S; Sadeh M; Shapira Y; Edvardson S; Daana M; Dor-Wollman T; Mimouni-Bloch A; Halevy A; Cohen R; Sagie L; Argov Z; Rabie M; Spiegel R; Chervinsky I; Orenstein N; Engel AG; Nevo Y
    Neuromuscul Disord; 2017 Feb; 27(2):136-140. PubMed ID: 28024842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Analysis of a Congenital Myasthenic Syndrome Due to a Pathogenic Variant Affecting the C-Terminus of ColQ.
    Barbeau S; Semprez F; Dobbertin A; Merriadec L; Roussange F; Eymard B; Sternberg D; Fournier E; Karasoy H; Martinat C; Legay C
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two novel mutations in the COLQ gene cause endplate acetylcholinesterase deficiency.
    Ishigaki K; Nicolle D; Krejci E; Leroy JP; Koenig J; Fardeau M; Eymard B; Hantaï D
    Neuromuscul Disord; 2003 Mar; 13(3):236-44. PubMed ID: 12609505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Congenital myasthenic syndrome in Turkey: clinical and genetic features in the long-term follow-up of patients.
    Gül Mert G; Özcan N; Hergüner Ö; Altunbaşak Ş; Incecik F; Bişgin A; Ceylaner S
    Acta Neurol Belg; 2021 Apr; 121(2):529-534. PubMed ID: 31773638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COOH-terminal collagen Q (COLQ) mutants causing human deficiency of endplate acetylcholinesterase impair the interaction of ColQ with proteins of the basal lamina.
    Arredondo J; Lara M; Ng F; Gochez DA; Lee DC; Logia SP; Nguyen J; Maselli RA
    Hum Genet; 2014 May; 133(5):599-616. PubMed ID: 24281389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapsyn congenital myasthenic syndrome worsened by fluoxetine.
    Visser AC; Laughlin RS; Litchy WJ; Benarroch EE; Milone M
    Muscle Nerve; 2017 Jan; 55(1):131-135. PubMed ID: 27397848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rare slow channel congenital myasthenic syndromes without repetitive compound muscle action potential and dramatic response to low dose fluoxetine.
    Durmus H; Sticht H; Ceylaner S; Hashemolhosseini S; Deymeer F
    Acta Neurol Belg; 2021 Dec; 121(6):1755-1760. PubMed ID: 33030681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delineation of molecular characteristics of congenital myasthenic syndromes in Indian families and review of literature.
    Mishra S; Nair KV; Shukla A
    Clin Dysmorphol; 2023 Oct; 32(4):162-167. PubMed ID: 37646703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Congenital myasthenic syndrome in Golden Retrievers is associated with a novel COLQ mutation.
    Tsai KL; Vernau KM; Winger K; Zwueste DM; Sturges BK; Knipe M; Williams DC; Anderson KJ; Evans JM; Guo LT; Clark LA; Shelton GD
    J Vet Intern Med; 2020 Jan; 34(1):258-265. PubMed ID: 31769119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SRSF1 and hnRNP H antagonistically regulate splicing of COLQ exon 16 in a congenital myasthenic syndrome.
    Rahman MA; Azuma Y; Nasrin F; Takeda J; Nazim M; Bin Ahsan K; Masuda A; Engel AG; Ohno K
    Sci Rep; 2015 Aug; 5():13208. PubMed ID: 26282582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.